Table II.
Device | Advantages | Limitations | Assumptions |
---|---|---|---|
Band electrode method | Noninvasive, low-cost, simple to use, continuous time-dependent monitoring Can give assessment of relative cardiac output changes in response to therapy |
Some questionable accuracy and consistency of cardiac output measurements for late-stage, chronic heart failure, and patients in unstable conditions Unresolved discrepancies in measurement (pulmonary edema, body size, irregular blood flow, blood volume) |
No valve defects No respiratory diseases No renal failure, no implanted pacing device |
Implanted device-based method | Noninvasive (external), early detection of symptoms before hospitalization Continuous monitoring Sensitive to fluid accumulation, localized to thorax |
Invasive (implant), some unresolved impedance sources (blood volume, lung resistivity) No cardiac output, SVR, or filling pressure monitor No detection of peripheral edema or hypertension |
No valve defects No acute pulmonary processes (eg, pneumonia) |